Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Kongliyuan Group is a Chinese pharmaceutical company headquartered in Haikou, Hainan. Established in 2003, the group specializes in the research, development, manufacturing, and distribution of a broad range of pharmaceutical products. Its portfolio includes antibiotics, cardiovascular drugs, and gastrointestinal medications. The company operates GMP-certified production lines for various dosage forms such as tablets, capsules, and small-volume injections. Hainan Kongliyuan Group is recognized for its strong presence in the domestic Chinese market, particularly through its primary subsidiary, Hainan Kongliyuan Pharmaceutical Co., Ltd. The group integrates R&D with large-scale manufacturing to provide affordable generic medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Kongliyuan Group.